Rich Poska serves as the Managing Director at Flexo LLC, where he leverages his extensive expertise in the formulation and processing of solid dosage forms to drive innovative solutions in the pharmaceutical industry. With a robust background in Chemistry, Manufacturing, and Controls (CMC), Rich has...
Rich Poska serves as the Managing Director at Flexo LLC, where he leverages his extensive expertise in the formulation and processing of solid dosage forms to drive innovative solutions in the pharmaceutical industry. With a robust background in Chemistry, Manufacturing, and Controls (CMC), Rich has established himself as a subject matter expert, particularly in navigating the complexities of regulatory strategies and quality assurance initiatives. His role involves consulting on critical projects that encompass the entire lifecycle of pharmaceutical development, from initial formulation design to comprehensive regulatory submissions.
At Flexo LLC, Rich is currently spearheading key projects that focus on optimizing formulation processes and enhancing product quality through rigorous validation practices. His deep understanding of regulatory affairs allows him to develop tailored strategies that align with both industry standards and client objectives, ensuring compliance while accelerating time-to-market for new therapies. Rich's proficiency in biopharmaceuticals and clinical development further enriches his consulting services, enabling him to provide insights that bridge the gap between scientific innovation and regulatory requirements.
Rich’s skills in validation, quality systems, and standard operating procedures (SOP) are instrumental in fostering a culture of excellence within the organization. He is committed to mentoring emerging professionals in the field, sharing his knowledge of V&V (Verification and Validation) processes to enhance their understanding of quality assurance in pharmaceutical development. Through his leadership at Flexo LLC, Rich Poska continues to make significant contributions to the advancement of solid dosage form technologies, positioning the company as a trusted partner in the pharmaceutical landscape.
